AI in Clinical Trials: Market Size, Trends & Growth Outlook
The integration of AI-based technologies in preclinical and clinical studies is becoming increasingly prevalent, transforming the landscape of drug development and research. These advanced tools present significant opportunities for pharmaceutical companies to enhance the precision and efficiency of their testing processes, ultimately accelerating the pace of drug development and optimizing research outcomes.